Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1045 | 1022 | 1131 | 961 | 1473 | 1511 |
Fund Return | 4.52% | 2.22% | 13.14% | -1.31% | 8.05% | 4.21% |
Place in category | 302 | 254 | 216 | 158 | 113 | 175 |
% in Category | 70 | 60 | 59 | 48 | 41 | 80 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Oppenheimer Developing Markets Y | 10.59B | 2.23 | -9.44 | 1.70 | ||
Oppenheimer Main Street A | 9.18B | 12.66 | 7.27 | 10.86 | ||
Oppenheimer Developing Markets I | 8.17B | 2.31 | -9.31 | 1.87 | ||
Oppenheimer Global A | 6.34B | 10.84 | 2.35 | 9.01 | ||
Oppenheimer Capital Appreciation A | 5.04B | 17.14 | 7.75 | 12.75 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
American Funds Europacific Growth R | 66.27B | 8.14 | -2.08 | 5.44 | ||
Vanguard International Growth Adm | 38.11B | 8.82 | -5.85 | 7.87 | ||
American Funds Europacific Growth F | 20.91B | 8.10 | -2.18 | 5.33 | ||
American Funds Europacific Growth A | 20.34B | 7.99 | -2.44 | 5.07 | ||
WCM Focused International Growth I | 18B | 10.15 | -0.49 | 9.30 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 5.80 | 991.0 | +1.15% | |
Reliance Industries | INE002A01018 | 3.63 | 2,955.10 | +0.84% | |
ASML Holding | NL0010273215 | 3.51 | 953.00 | -1.40% | |
Louis Vuitton | FR0000121014 | 3.42 | 711.40 | -2.75% | |
Dollarama | CA25675T1075 | 3.16 | 123.85 | +1.87% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Neutral | Buy |
Technical Indicators | Strong Sell | Strong Buy | BUY |
Summary | Strong Sell | Buy | Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review